Folic Acid-Guided PLGA-Zein Core–Shell Nanoparticles for Co-Delivery of Temozolomide and Ellagic Acid to Overcome PARP-Mediated Chemoresistance in Glioblastoma
Arunraj Tharamelveliyil Rajendran, Ashwini Prabhu, Ashwini Madhava, Anoop Narayanan Vadakkepushpakath · 2026
Read Folic Acid-Guided PLGA-Zein Core–Shell Nanoparticles for Co-Delivery of Temozolomide and Ellagic Acid to Overcome PARP-Mediated Chemoresistance in Glioblastoma by Arunraj Tharamelveliyil Rajendran, Ashwini Prabhu, Ashwini Madhava, Anoop Narayanan Vadakkepushpakath (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13304799.txt.
Description
Arunraj Tharamelveliyil Rajendran, Ashwini Prabhu, and colleagues engineer, in a 2026 nanomedicine study, a two-drug particle aimed at resistant glioblastoma. The brain tumor shrugs off its standard drug partly by repairing DNA damage through the PARP enzyme, and the blood–brain barrier blocks reinforcements. Their core–shell particle pairs that standard drug with ellagic acid, a plant compound that inhibits PARP, and steers it with folic acid.
The particles formed evenly, held both drugs stably, and released them in a sustained two-phase pattern. Folic acid coating sharply increased uptake into glioblastoma cells, and the drug pair killed synergistically at much lower doses than either alone. Treated cells showed more DNA damage, more programmed death, less migration, and reduced PARP gene activity. The authors offer the platform as groundwork for translation.
Catalog record
| CREATOR | Arunraj Tharamelveliyil Rajendran, Ashwini Prabhu, Ashwini Madhava, Anoop Narayanan Vadakkepushpakath |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 101 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |